Two Sigma Investments’s CinCor Pharma, Inc. Common Stock CINC Stock Holding History

Two Sigma Investments’s Portfolio CINC Stock Details CINC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-115,864	Closed	-$1.42M	–	3334
2022 Q4	$1.42M	Buy	+115,864	New	+$2.76M	﹤0.01%	1514

Two Sigma Investments's CINC Position: Q1 2023 in Review

Two Sigma Investments sold out of CinCor Pharma, Inc. Common Stock (CINC) in Q1 2023, closing a stake of 115,864 shares — an estimated $1.42M sold.

Two Sigma Investments first reported a position in CINC in Q4 2022 and held it in 1 quarter. The position peaked at $1.42M in Q4 2022. 0 funds tracked by Wall St. Rank hold CINC as of Q1 2023.

Two Sigma Investments reported no remaining CinCor Pharma, Inc. Common Stock position as of Q1 2023 after selling out during the quarter.
Two Sigma Investments sold 115,864 CinCor Pharma, Inc. Common Stock shares in Q1 2023, an estimated $1.42M.
Two Sigma Investments first reported a position in CinCor Pharma, Inc. Common Stock in Q4 2022 and held it in 1 quarter.
Two Sigma Investments's CinCor Pharma, Inc. Common Stock position peaked at $1.42M in Q4 2022.
0 funds tracked by Wall St. Rank held CinCor Pharma, Inc. Common Stock as of Q1 2023.

Based on Two Sigma Investments's 13F filing for Q1 2023, filed 15 May 2023.